RESEARCHER PROFILE
Frank Onyambu
← Back to Meru University of Science and Technology
F
Meru University of Science and Technology
Frank Onyambu works in Infections and bacterial resistance, Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Antibiotic Resistance in Bacteria, Escherichia coli research studies. Recorded institutional associations include Meru University of Science and Technology.
15Publications
0Citations
0H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Peer Review Report For: Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in nontuberculous mycobacteria isolates from Kenya [version 2; peer review: 1 approved, 1 not approved]
2022 · 0 citationsPeer Review Report For: Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in nontuberculous mycobacteria isolates from Kenya [version 2; peer review: 1 approved, 1 not approved]
2022 · 0 citationsPeer Review Report For: Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in nontuberculous mycobacteria isolates from Kenya [version 4; peer review: 1 approved, 1 approved with reservations, 1 not approved]
2023 · 0 citationsPeer Review Report For: Draft genome sequences of three emerging beta-lactamase-producing Escherichia coli in the camel production system in Northern Kenya [version 2; peer review: 2 approved]
2023 · 0 citationsPeer Review Report For: Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in non-tuberculous mycobacteria isolates from Kenya [version 5; peer review: 2 approved, 1 not approved]
2023 · 0 citationsPeer Review Report For: Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in nontuberculous mycobacteria isolates from Kenya [version 1; peer review: 2 approved with reservations]
2022 · 0 citationsPeer Review Report For: Draft genome of a clinical Pseudomonas qingdaonensis isolate from a hospitalized patient at Kenyatta National Hospital, Kenya [version 1; peer review: 2 approved]
2023 · 0 citationsPeer Review Report For: Draft genome sequences of three emerging beta-lactamase-producing Escherichia coli in the camel production system in Northern Kenya [version 1; peer review: 1 approved, 1 approved with reservations]
2023 · 0 citationsPeer Review Report For: Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in nontuberculous mycobacteria isolates from Kenya [version 3; peer review: 1 approved, 1 not approved]
2022 · 0 citationsPeer Review Report For: Draft genome of a clinical Pseudomonas qingdaonensis isolate from a hospitalized patient at Kenyatta National Hospital, Kenya [version 1; peer review: 2 approved]
2023 · 0 citationsPeer Review Report For: Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in nontuberculous mycobacteria isolates from Kenya [version 4; peer review: 1 approved, 1 approved with reservations, 1 not approved]
2023 · 0 citationsPeer Review Report For: Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in nontuberculous mycobacteria isolates from Kenya [version 1; peer review: 2 approved with reservations]
2022 · 0 citationsGenomic characterization of Escherichia coli and Enterobacter hormaechei clinical isolates from a tertiary healthcare facility in Kenya
2026 · 0 citationsDeterminants of triple-negative breast cancer among African patients: Early results from The African Cancer Atlas.
2026 · 0 citationsEarly lessons from the implementation of a pan-African clinico-genomic cancer platform: The African Cancer Atlas.
2026 · 0 citations
